Nov 12 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* ITERUM THERAPEUTICS PLC - CASH RUNWAY INTO 2024
* ITERUM THERAPEUTICS PLC - TYPE B MEETING WITH FDA
REQUESTED TO
AFFIRM DESIGN FOR ADDITIONAL PHASE 3 TRIAL NEEDED FOR
RESUBMISSION OF NDA FOR ORAL SULOPENEM
* ITERUM THERAPEUTICS PLC - FOR Q3 OF 2021, ITERUM REPORTED
NET
INCOME OF $3.7 MILLION
Source text for Eikon: ID:nGNXc2Zcpy
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))